BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 234915)

  • 1. Temporal appearance of opsonizing antibody to Francisella tularensis: detection by a radiometabolic assay.
    Canonico PG; McManus AT; Mangiafico JA; Sammons LS; McGann VG; Dangerfield HG
    Infect Immun; 1975 Mar; 11(3):466-9. PubMed ID: 234915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phagocytosis of Francisella tularensis by Rhesus monkey peripheral leukocytes.
    Proctor RA; White JD; Ayala E; Canonico PG
    Infect Immun; 1975 Jan; 11(1):146-51. PubMed ID: 234911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of opsonizing antibodies to Francisella tularensis by leukocyte chemiluminescence.
    Löfgren S; Tärnvik A; Carlsson J
    Infect Immun; 1980 Aug; 29(2):329-34. PubMed ID: 7216416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and immunological properties of ribonucleic acid-rich extracts from Francisella tularensis.
    Andron LA II; Eigelsbach HT
    Infect Immun; 1975 Jul; 12(1):137-42. PubMed ID: 237834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The opsonizing activity of the sera of hamadryas baboons immunized with a preparation of the outer membranes of Francisella tularensis (based on data from the luminol-dependent luminescence method)].
    Komarov AM; Iurov SV; Pchelintsev SIu; Khlebnikov VS; Arshinov AM; Vorob'ev AA; Afanas'ev SS; Urakov NN
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Apr; (4):47-51. PubMed ID: 1496878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of complement opsonization in interactions between F. tularensis subsp. novicida and human neutrophils.
    Barker JH; McCaffrey RL; Baman NK; Allen LA; Weiss JP; Nauseef WM
    Microbes Infect; 2009; 11(8-9):762-9. PubMed ID: 19409509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural IgM mediates complement-dependent uptake of Francisella tularensis by human neutrophils via complement receptors 1 and 3 in nonimmune serum.
    Schwartz JT; Barker JH; Long ME; Kaufman J; McCracken J; Allen LA
    J Immunol; 2012 Sep; 189(6):3064-77. PubMed ID: 22888138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes.
    Sandström G; Löfgren S; Tärnvik A
    Infect Immun; 1988 May; 56(5):1194-202. PubMed ID: 3356465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detrimental Influence of Alveolar Macrophages on Protective Humoral Immunity during Francisella tularensis SchuS4 Pulmonary Infection.
    Steiner DJ; Furuya Y; Metzger DW
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phagocytosis and killing of Francisella tularensis by human polymorphonuclear leukocytes.
    Löfgren S; Tärnvik A; Bloom GD; Sjöberg W
    Infect Immun; 1983 Feb; 39(2):715-20. PubMed ID: 6832815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibody dynamics of carnivorous mammals and corvine birds infected with Francisella tularensis].
    Sukhanov NA
    Zh Mikrobiol Epidemiol Immunobiol; 1984 May; (5):105-8. PubMed ID: 6741361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative analysis of the immune response of a rabbit to antigens to live and killed Francisella species bacteria].
    Aronova NV; Pavlovich NV
    Mol Gen Mikrobiol Virusol; 2001; (2):26-30. PubMed ID: 11449797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phase variations of Francisella tularensis lipopolysaccharide in human infection and immunization].
    Aronova NV; Pavlovich NV
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (4):8-12. PubMed ID: 16146218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated and humoral immunity induced by a live Francisella tularensis vaccine.
    Koskela P; Herva E
    Infect Immun; 1982 Jun; 36(3):983-9. PubMed ID: 7095859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of tularemia antibodies by an immunoenzyme method on a solid-phase carrier (ELISA)].
    Umnova NS; Shakhanina KL; Meshcheriakova IS; Pavlova IP
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Apr; (4):79-83. PubMed ID: 6377770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A serological survey of antibodies against Francisella tularensis in some Swedish mammals.
    Mörner T; Sandstedt K
    Nord Vet Med; 1983 Feb; 35(2):82-5. PubMed ID: 6878028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use if Francisella tularensis lipopolysaccharide in the dot solid phase enzyme immunoassay].
    Aronova NV; Pavlovich NV
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (5):75-8. PubMed ID: 11220974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The immunological efficacy of Francisella tularensis outer membranes for hamadryas baboons].
    Khlebnikov VS; Golovlev IR; Zhemchugov VE; Chugunov AM; Averin SF; Afanas'ev SS; Kalachev IIa; Pchelintsev SIu; Kislichkin NN
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (3):61-4. PubMed ID: 7941871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of antibodies to Francisella tularensis antigens during the acute phase of tularemia and eight years later.
    Bevanger L; Maeland JA; Kvan AI
    Clin Diagn Lab Immunol; 1994 Mar; 1(2):238-40. PubMed ID: 7496953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of complement on the chemiluminescent response of human leukocytes to immune complex.
    Löfgren S; Tärnvik A; Carlsson J
    Infect Immun; 1980 Aug; 29(2):335-41. PubMed ID: 7011971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.